Abstract
Summary: The carnitine transporter defect (McKusick 212140) is an autosomal recessive disorder caused by mutations in the SLC22A5 gene, which encodes the high-affinity carnitine transporter OCTN2 (Wang et al 2001). Diagnosis is suspected when plasma carnitine levels are extremely low and secondary causes of carnitine loss are excluded. The disease can present with recurrent Reye-like episodes of hypoketotic hypoglycaemia or with cardiomyopathy associated with myopathy (Stanley et al 1991). Here we report novel clinical findings in a 3-year-old with primary carnitine deficiency.
This is a preview of subscription content, log in via an institution to check access.
REFERENCES
Spiekerkoetter U, Huenger G, Baykal T,et al (2003)Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2.J Inherit Metab Dis 26:613-615.
Stanley CA, Deleeuw S, Coates PM,et al (1991)Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake.Ann Neurol 30:709-716.
Wang Y, Taroni F, Garavaglia B, Longo N (2000)Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency:lack of genotype-phenotype correlation.Hum Mutat 16:401-407.
Wang Y, Korman SH, Ye J (2001)Phenotype and genotype variation in primary carnitine deficiency.Genet Med 3:387-392.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Makhseed, N., Vallance, H., Potter, M. et al. Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy. J Inherit Metab Dis 27, 778–780 (2004). https://doi.org/10.1023/B:BOLI.0000045837.23328.f4
Issue Date:
DOI: https://doi.org/10.1023/B:BOLI.0000045837.23328.f4